In 2023, Germany dominated European diuretic medicine sales with a significant value of 600.2 million euros, showing a year-on-year growth of 4.13%. Italy and Spain followed with 121.5 and 120.1 million euros respectively, experiencing moderate growth. Austria showed the highest year-on-year growth rate at 6.34%. Conversely, Greece and Luxembourg experienced declines, with Greece seeing a sharp decrease of 7.11%. Portugal and Finland had slightly negative and positive growths, respectively.
Future trends to watch include:
- Germany's continued market leadership and its potential impact on competition.
- Recovery strategies in Greece amid declining sales.
- Increased demand in emerging markets like Austria and Finland.
- Potential regulatory changes within the EU impacting sales dynamics.
Top countries in Diuretic Medicine Sales by Country
| # | 8 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 600.2 | 2023 | +1.15% | +4.13% | View data |
| 2 | 2 Italy | 121.5 | 2023 | +3.85% | +1.05% | View data |
| 3 | 3 Spain | 120.1 | 2023 | -0.17% | +1.48% | View data |
| 4 | 4 Austria | 27.2 | 2023 | +4.21% | +6.34% | View data |
| 5 | 5 Greece | 23.1 | 2023 | 0% | -7.11% | View data |
| 6 | 6 Portugal | 20.5 | 2023 | -2.38% | -1.04% | View data |
| 7 | 7 Finland | 9.2 | 2023 | 0% | +2.33% | View data |
| 8 | 8 Luxembourg | 1.3 | 2023 | 0% | -1.47% | View data |
